Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001390816 | SCV001592664 | pathogenic | Cataract 15 multiple types | 2020-11-05 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant has been reported to affect MIP protein function (PMID: 24120416). This variant has been observed in individual(s) with congenital cataracts (PMID: 26694549, 29770612). In at least one individual the variant was observed to be de novo. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 217342). This variant is not present in population databases (ExAC no frequency). This sequence change replaces arginine with cysteine at codon 33 of the MIP protein (p.Arg33Cys). The arginine residue is moderately conserved and there is a large physicochemical difference between arginine and cysteine. |
Genetics Department, |
RCV002512064 | SCV002822863 | pathogenic | Persistent hyperplastic primary vitreous | 2023-01-17 | criteria provided, single submitter | clinical testing | |
Eye Genetics Research Group, |
RCV000203320 | SCV000256024 | pathogenic | Developmental cataract | 2015-01-09 | no assertion criteria provided | research |